Ebersberg, Germany

Thomas Rapolder

This inventor holds 1 USPTO granted patent. Top assignee: Lisa Draexlmaier Gmbh. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Rapolder: Innovator in Semiconductor Monitoring

Introduction

Thomas Rapolder is a notable inventor based in Ebersberg, Germany. He has made significant contributions to the field of semiconductor technology. His innovative approach focuses on enhancing the reliability and safety of semiconductor components.

Latest Patents

Rapolder holds a patent for a "Method for monitoring a switchable semiconductor component and monitoring device for a semiconductor component." This method involves monitoring a switchable semiconductor component equipped with a protective circuit. It includes tapping an electrical variable applied to both the semiconductor component and the protective circuit. The invention aims to detect damage to the semiconductor component and/or the protective circuit when an electrical variable exceeds a known critical value. This advancement is crucial for improving the performance and longevity of semiconductor devices.

Career Highlights

Thomas Rapolder is currently employed at Lisa Draexlmaier GmbH, where he continues to work on innovative solutions in semiconductor technology. His expertise and dedication to his field have positioned him as a valuable asset to his company.

Collaborations

Rapolder collaborates with Michael Wortberg, a fellow professional in the industry. Their combined efforts contribute to the development of cutting-edge technologies in semiconductor monitoring.

Conclusion

Thomas Rapolder's work in semiconductor monitoring exemplifies the importance of innovation in technology. His patent and ongoing contributions reflect a commitment to enhancing the reliability of electronic components.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…